Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

986 ARTÍCULOS , VIENDO DEL 916 AL 930

Opalski syndrome: A comprehensive systematic review of cases

Rezaei Zadeh Rukerd M, Mirkamali H, Alizadeh SD.

Clin Neurol Neurosurg. 2024 Oct;245:108474. doi: 10.1016/j.clineuro.2024.108474. Epub 2024 Jul 31.

Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment

Soto-Piña AE, Pulido-Alvarado CC, Dulski J, Wszolek ZK, Magaña JJ.

Int J Mol Sci. 2024 Jul 24;25(15):8074. doi: 10.3390/ijms25158074.

Oxidative stress and the multifaceted roles of ATM in maintaining cellular redox homeostasis

Lee JH.

Redox Biol. 2024 Sep;75:103269. doi: 10.1016/j.redox.2024.103269. Epub 2024 Jul 16.

ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3

Hernández-Carralero E, Quinet G, Freire R.

Expert Rev Mol Med. 2024 Sep 25;26:e19. doi: 10.1017/erm.2024.10.

Trans-Spinal Theta Burst Magnetic Stimulation in Parkinson's Disease and Gait Disorders

Menezes JR, Nunes GA, Carra RB, da Silva Simões J, Solla DJF, Oliveira JR, Teixeira MJ, Marcolin MA, Barbosa ER, Tanaka C, de Andrade DC, Cury RG.

Mov Disord. 2024 Jun;39(6):1048-1053. doi: 10.1002/mds.29776. Epub 2024 Mar 13.

Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers

Coarelli G, Dubec-Fleury C, Petit E, Sayah S, Fischer C, Nassisi M, Gatignol P, Dorgham K, Daghsen L, Daye P, Cunha P, Kacher R, Hilab R, Hurmic H, Lamazière A, Lamy JC, Welter ML, Chupin M, Mangin JF, Lane R, Gaymard B, Pouget P, Audo I, Brice A, Tezenas du Montcel S, Durr A.

Neurology. 2024 Sep 10;103(5):e209749. doi: 10.1212/WNL.0000000000209749. Epub 2024 Aug 12.

Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review

Umrao A, Pahuja M, Chatterjee NS.

Orphanet J Rare Dis. 2024 Dec 30;19(1):495. doi: 10.1186/s13023-024-03474-6.

Targeting shelterin proteins for cancer therapy

Brankiewicz-Kopcinska W, Kallingal A, Krzemieniecki R, Baginski M.

Drug Discov Today. 2024 Aug;29(8):104056. doi: 10.1016/j.drudis.2024.104056. Epub 2024 Jun 4.

Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia

Presterud R, Deng WH, Wennerström AB, Burgers T, Gajera B, Mattsson K, Solberg A, Fang EF, Nieminen AI, Stray-Pedersen A, Nilsen H.

Mov Disord. 2024 Feb;39(2):360-369. doi: 10.1002/mds.29645. Epub 2023 Oct 29.

Skeletal Muscle Involvement in Friedreich Ataxia

Indelicato E, Wanschitz J, Löscher W, Boesch S.

Int J Mol Sci. 2024 Sep 13;25(18):9915. doi: 10.3390/ijms25189915.

Tremor in Spinocerebellar Ataxia: A Scoping Review

Mukherjee A, Pandey S.

Tremor Other Hyperkinet Mov (N Y). 2024 Jun 20;14:31. doi: 10.5334/tohm.911. eCollection 2024.

Effects and safety of transcranial direct current stimulation on multiple health outcomes: an umbrella review of randomized clinical trials

Kang J, Lee H, Yu S, Lee M, Kim HJ, Kwon R, Kim S, Fond G, Boyer L, Rahmati M, Koyanagi A, Smith L, Nehs CJ, Kim MS, Sánchez GFL, Dragioti E, Kim T, Yon DK.

Mol Psychiatry. 2024 Dec;29(12):3789-3801. doi: 10.1038/s41380-024-02624-3. Epub 2024 May 30.

Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)

Schiffmann R, Mengel E, Wallace M, Rochmann C, Turnbull J, Krupnick R, Gwaltney C, Pulikottil-Jacob R, Batsu I, Zheng R, Hamed A.

Adv Ther. 2024 Jul;41(7):2907-2923. doi: 10.1007/s12325-024-02881-2. Epub 2024 May 27.

Patient-Relevant Digital-Motor Outcomes for Clinical Trials in Hereditary Spastic Paraplegia Type 7: A Multicenter PROSPAX Study

Beichert L, Seemann J, Kessler C, Traschütz A, Müller D, Dillmann-Jehn K, Ricca I, Satolli S, Basak NA, Coarelli G, Timmann D, Gagnon C, van de Warrenburg BPC; PROSPAX Consortium; Ilg W, Synofzik M, Schüle R.

Neurology. 2024 Dec 24;103(12):e209887. doi: 10.1212/WNL.0000000000209887. Epub 2024 Dec 2.

Therapeutic Biomarkers in Friedreich's Ataxia: a Systematic Review and Meta-analysis

Gavriilaki M, Chatzikyriakou E, Moschou M, Arnaoutoglou M, Sakellari I, Kimiskidis VK.

Cerebellum. 2024 Jun;23(3):1184-1203. doi: 10.1007/s12311-023-01621-6. Epub 2023 Oct 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias